| Literature DB >> 19851773 |
Paola Sabrina Buonuomo1, Claudia Bracaglia, Andrea Campana, Antonella Insalaco, Manuela Pardeo, Elisabetta Cortis, Alberto G Ugazio.
Abstract
Takayasu arteritis (TA) is a chronic vasculitis of unknown etiology. Experience with anti-tumor necrosis factor alpha (anti-TNF) agents in difficult-to-treat patients with TA is limited and refers to adult patients. Here, we present two cases of pediatric TA treated with infliximab, in which clinical remission was observed. Anti-TNF treatment represents a useful therapy in pediatric Takayasu arteritis too, especially to avoid the risk of long-term corticosteroids toxicity.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19851773 DOI： 10.1007/s00296-009-1147-5
Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631